The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.

Abstract Background The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has presented itself as one of the most important health concerns of the 2020’s, and hit the geriatric population the hardest. The presence of co-morbidities and immune ageing in th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maria E. Goossens, Kristof Y. Neven, Pieter Pannus, Cyril Barbezange, Isabelle Thomas, Steven Van Gucht, Katelijne Dierick, Marie-Noëlle Schmickler, Mathieu Verbrugghe, Nele Van Loon, Kevin K Ariën, Arnaud Marchant, Stanislas Goriely, Isabelle Desombere
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
ILI
ARI
Acceso en línea:https://doaj.org/article/652b67052c384ece8d129e39d17050d2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:652b67052c384ece8d129e39d17050d2
record_format dspace
spelling oai:doaj.org-article:652b67052c384ece8d129e39d17050d22021-11-14T12:15:06ZThe prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.10.1186/s13690-021-00715-z2049-3258https://doaj.org/article/652b67052c384ece8d129e39d17050d22021-11-01T00:00:00Zhttps://doi.org/10.1186/s13690-021-00715-zhttps://doaj.org/toc/2049-3258Abstract Background The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has presented itself as one of the most important health concerns of the 2020’s, and hit the geriatric population the hardest. The presence of co-morbidities and immune ageing in the elderly lead to an increased susceptibility to COVID-19, as is the case for other influenza-like illnesses (ILI) or acute respiratory tract infections (ARI). However, little is known, about the impact of a previous or current infection on the other in terms of susceptibility, immune response, and clinical course. The aim of the “Prior Infection with SARS-COV-2” (PICOV) study is to compare the time to occurrence of an ILI or ARI between participants with a confirmed past SARS-CoV-2 infection (previously infected) and those without a confirmed past infection (naïve) in residents and staff members of nursing homes. This paper describes the study design and population characteristics at baseline. Methods In 26 Belgian nursing homes, all eligible residents and staff members were invited to participate, resulting in 1,226 participants. They were classified as naïve or previously infected based on the presence of detectable SARS-CoV-2 antibodies and/or a positive RT-qPCR result before participation in the study. Symptoms from a prior SARS-CoV-2 infection between March and August 2020 were compared between previously infected residents and staff members. Results Infection naïve nursing home residents reported fewer symptoms than previously infected residents: on average 1.9 and 3.1 symptoms, respectively (p = 0.016). The same effect was observed for infection naïve staff members and previously infected staff members (3.1 and 6.1 symptoms, respectively; p <0.0001). Moreover, the antibody development after a SARS-CoV-2 infection differs between residents and staff members, as previously infected residents tend to have a higher rate of asymptomatic cases compared to previously infected staff members (20.5% compared to 12.4%; p <0.0001). Conclusions We can postulate that COVID-19 disease development and symptomatology are different between a geriatric and younger population. Therefore, the occurrence and severity of a future ILI and/or ARI might vary from resident to staff.Maria E. GoossensKristof Y. NevenPieter PannusCyril BarbezangeIsabelle ThomasSteven Van GuchtKatelijne DierickMarie-Noëlle SchmicklerMathieu VerbruggheNele Van LoonKevin K AriënArnaud MarchantStanislas GorielyIsabelle DesombereBMCarticleSARS-CoV-2COVID-19ILIARIMulticentricCohortPublic aspects of medicineRA1-1270ENArchives of Public Health, Vol 79, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic SARS-CoV-2
COVID-19
ILI
ARI
Multicentric
Cohort
Public aspects of medicine
RA1-1270
spellingShingle SARS-CoV-2
COVID-19
ILI
ARI
Multicentric
Cohort
Public aspects of medicine
RA1-1270
Maria E. Goossens
Kristof Y. Neven
Pieter Pannus
Cyril Barbezange
Isabelle Thomas
Steven Van Gucht
Katelijne Dierick
Marie-Noëlle Schmickler
Mathieu Verbrugghe
Nele Van Loon
Kevin K Ariën
Arnaud Marchant
Stanislas Goriely
Isabelle Desombere
The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.
description Abstract Background The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has presented itself as one of the most important health concerns of the 2020’s, and hit the geriatric population the hardest. The presence of co-morbidities and immune ageing in the elderly lead to an increased susceptibility to COVID-19, as is the case for other influenza-like illnesses (ILI) or acute respiratory tract infections (ARI). However, little is known, about the impact of a previous or current infection on the other in terms of susceptibility, immune response, and clinical course. The aim of the “Prior Infection with SARS-COV-2” (PICOV) study is to compare the time to occurrence of an ILI or ARI between participants with a confirmed past SARS-CoV-2 infection (previously infected) and those without a confirmed past infection (naïve) in residents and staff members of nursing homes. This paper describes the study design and population characteristics at baseline. Methods In 26 Belgian nursing homes, all eligible residents and staff members were invited to participate, resulting in 1,226 participants. They were classified as naïve or previously infected based on the presence of detectable SARS-CoV-2 antibodies and/or a positive RT-qPCR result before participation in the study. Symptoms from a prior SARS-CoV-2 infection between March and August 2020 were compared between previously infected residents and staff members. Results Infection naïve nursing home residents reported fewer symptoms than previously infected residents: on average 1.9 and 3.1 symptoms, respectively (p = 0.016). The same effect was observed for infection naïve staff members and previously infected staff members (3.1 and 6.1 symptoms, respectively; p <0.0001). Moreover, the antibody development after a SARS-CoV-2 infection differs between residents and staff members, as previously infected residents tend to have a higher rate of asymptomatic cases compared to previously infected staff members (20.5% compared to 12.4%; p <0.0001). Conclusions We can postulate that COVID-19 disease development and symptomatology are different between a geriatric and younger population. Therefore, the occurrence and severity of a future ILI and/or ARI might vary from resident to staff.
format article
author Maria E. Goossens
Kristof Y. Neven
Pieter Pannus
Cyril Barbezange
Isabelle Thomas
Steven Van Gucht
Katelijne Dierick
Marie-Noëlle Schmickler
Mathieu Verbrugghe
Nele Van Loon
Kevin K Ariën
Arnaud Marchant
Stanislas Goriely
Isabelle Desombere
author_facet Maria E. Goossens
Kristof Y. Neven
Pieter Pannus
Cyril Barbezange
Isabelle Thomas
Steven Van Gucht
Katelijne Dierick
Marie-Noëlle Schmickler
Mathieu Verbrugghe
Nele Van Loon
Kevin K Ariën
Arnaud Marchant
Stanislas Goriely
Isabelle Desombere
author_sort Maria E. Goossens
title The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.
title_short The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.
title_full The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.
title_fullStr The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.
title_full_unstemmed The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.
title_sort prior infection with sars-cov-2 study (picov) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.
publisher BMC
publishDate 2021
url https://doaj.org/article/652b67052c384ece8d129e39d17050d2
work_keys_str_mv AT mariaegoossens thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT kristofyneven thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT pieterpannus thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT cyrilbarbezange thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT isabellethomas thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT stevenvangucht thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT katelijnedierick thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT marienoelleschmickler thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT mathieuverbrugghe thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT nelevanloon thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT kevinkarien thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT arnaudmarchant thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT stanislasgoriely thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT isabelledesombere thepriorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT mariaegoossens priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT kristofyneven priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT pieterpannus priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT cyrilbarbezange priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT isabellethomas priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT stevenvangucht priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT katelijnedierick priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT marienoelleschmickler priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT mathieuverbrugghe priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT nelevanloon priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT kevinkarien priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT arnaudmarchant priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT stanislasgoriely priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
AT isabelledesombere priorinfectionwithsarscov2studypicovinnursinghomeresidentsandstaffstudyprotocoldescriptionandpresentationofpreliminaryfindingsonsymptoms
_version_ 1718429349868208128